GB202108867D0 - Screening system - Google Patents

Screening system

Info

Publication number
GB202108867D0
GB202108867D0 GBGB2108867.9A GB202108867A GB202108867D0 GB 202108867 D0 GB202108867 D0 GB 202108867D0 GB 202108867 A GB202108867 A GB 202108867A GB 202108867 D0 GB202108867 D0 GB 202108867D0
Authority
GB
United Kingdom
Prior art keywords
screening system
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108867.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Priority to GBGB2108867.9A priority Critical patent/GB202108867D0/en
Publication of GB202108867D0 publication Critical patent/GB202108867D0/en
Priority to PCT/EP2022/066779 priority patent/WO2022268745A1/en
Priority to US18/570,418 priority patent/US20240426807A1/en
Priority to EP22735386.9A priority patent/EP4359431A1/en
Priority to JP2023578936A priority patent/JP2024522842A/ja
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GBGB2108867.9A 2021-06-21 2021-06-21 Screening system Ceased GB202108867D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB2108867.9A GB202108867D0 (en) 2021-06-21 2021-06-21 Screening system
PCT/EP2022/066779 WO2022268745A1 (en) 2021-06-21 2022-06-21 Screening system
US18/570,418 US20240426807A1 (en) 2021-06-21 2022-06-21 Screening system
EP22735386.9A EP4359431A1 (en) 2021-06-21 2022-06-21 Screening system
JP2023578936A JP2024522842A (ja) 2021-06-21 2022-06-21 スクリーニング系

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108867.9A GB202108867D0 (en) 2021-06-21 2021-06-21 Screening system

Publications (1)

Publication Number Publication Date
GB202108867D0 true GB202108867D0 (en) 2021-08-04

Family

ID=77050466

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108867.9A Ceased GB202108867D0 (en) 2021-06-21 2021-06-21 Screening system

Country Status (5)

Country Link
US (1) US20240426807A1 (https=)
EP (1) EP4359431A1 (https=)
JP (1) JP2024522842A (https=)
GB (1) GB202108867D0 (https=)
WO (1) WO2022268745A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11867685B2 (en) 2017-12-05 2024-01-09 Chemcom S.A. Olfactory receptor involved in the perception of musk fragrance and the use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006002161A2 (en) 2004-06-18 2006-01-05 Duke University Modulators of odorant receptors
WO2014037800A2 (en) 2012-09-10 2014-03-13 Johns Hopkins University Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
WO2019110630A1 (en) 2017-12-05 2019-06-13 Chemcom S.A. Olfactory receptor involved in the perception of musk fragrance and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015062356A (ja) * 2013-09-24 2015-04-09 株式会社豊田中央研究所 嗅覚受容体を用いた匂い分子の評価方法
JP6504659B2 (ja) * 2015-05-13 2019-04-24 株式会社豊田中央研究所 嗅覚受容体を用いたにおい評価
EP3649236A4 (en) * 2017-07-05 2021-04-07 The Regents of The University of California Multiplexed receptor-ligand interaction screens

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006002161A2 (en) 2004-06-18 2006-01-05 Duke University Modulators of odorant receptors
WO2014037800A2 (en) 2012-09-10 2014-03-13 Johns Hopkins University Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
WO2019110630A1 (en) 2017-12-05 2019-06-13 Chemcom S.A. Olfactory receptor involved in the perception of musk fragrance and the use thereof

Non-Patent Citations (34)

* Cited by examiner, † Cited by third party
Title
"Genbank", Database accession no. 219981
ALASBAHIMELZIG, PHARMAZIE, vol. 67, no. 1, 2012, pages 5 - 13
ALTSCHU ET AL.: "J. Mol. Biol.", vol. 215, 1990, pages: 403 - 10
ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402
AUSUBEL ET AL.: "Current Protocols in Molecular Biology", 2003, JOHN WILEY & SONS INC
BROWNGENOMES, GARLAND SCIENC, 2017
CHALFIEKAIN: "Methods of Biochemical Analysis", 2005, WILEY-LISS, article "Green Fluorescent Protein: Properties, Applications and Protocols"
CONKLIN ET AL., NATURE, vol. 363, 1993, pages 274 - 276
DEANGELISWOODROW, MOL BIOTECHNOL, vol. 38, no. 2, 2008, pages 179 - 183
FEDDERSEN ET AL., BMC GENOMICS, vol. 20, 2019, pages 497
HENIKOFFHENIKOFF, PNAS, vol. 89, 1992, pages 915 - 919
KANDEL ET AL.: "PNAS", vol. 102, 2005, pages: 6425 - 30
KASPER ET AL., METHODS MOL BIOL, vol. 1453, 2016, pages 123 - 36
KUNKEL, PROC. NATL. ACAD. SCI., vol. 82, 1985, pages 488
LAMBERT, NATURE METHODS, vol. 16, 2019, pages 277 - 278
MAINLAND ET AL., SCI DATA, vol. 2, 2015, pages 150002
MALNIC ET AL., PNAS, vol. 101, no. 8, 2004, pages 2584 - 9
MONTINI ET AL., J CLIN INVEST, vol. 119, 2009, pages 964 - 75
MOUNT D.: "Bioinformatics: Sequence and Genome Analysis", 2004, COLD SPRING HARBOR LABORATORY PRESS
OLENDER ET AL., METHODS MOL BIOL, vol. 1003, 2013, pages 23 - 38
RANZANI ET AL., CURR PROTOC MOL BIOL, 2013
RANZANI ET AL., MOL THER, vol. 22, no. 12, 2014, pages 2056 - 2068
ROBERTS ET AL., NATURE, vol. 328, 1987, pages 731 734
SAITO ET AL., CELL, vol. 119, no. 5, 2004, pages 679 - 691
SCHWALBE R. ET AL.: "Boca Raton", 2007, CRC PRESS, article "Antimicrobial susceptibility testing protocols"
SHEPARD ET AL., PLOS ONE, vol. 8, no. 7, 2013, pages e68758
TOLLEFSBOL: "Handbook of Epigenetics: The New Molecular and Medical Genetics", 2017, ACADEMIC PRESS
TRIMMER ET AL., PNAS, vol. 116, no. 19, 2019, pages 9475 - 9480
WELLS, J.A. ET AL., GENE, vol. 34, 1985, pages 315
XIA X: "Cell: Modern Computational Approaches in Genomics, Proteomics and transcriptomics", 2018, SPRINGER INTERNATIONAL PUBLISHING
YANG ET AL.: "Gene Correction. Methods in Molecular Biology (Methods and Protocols", 2014, HUMANA PRESS, pages: 1114
YU ET AL., PLOS ONE, vol. 12, no. 6, 2017, pages e0179067
ZHANGFIRESTEIN, NATURE NEUROSCI, vol. 5, no. 2, 2002, pages 124 - 33
ZHUANGMATSUNAMI, J BIOL CHEM, vol. 282, no. 20, 2007, pages 15284 - 15293

Also Published As

Publication number Publication date
JP2024522842A (ja) 2024-06-21
US20240426807A1 (en) 2024-12-26
WO2022268745A1 (en) 2022-12-29
EP4359431A1 (en) 2024-05-01

Similar Documents

Publication Publication Date Title
IL286570A (en) editorial board
GB2597191B (en) Product-display system
GB202201775D0 (en) System
HUE056001T2 (hu) Szitáló berendezés
GB2605606B (en) A screening system
GB202108867D0 (en) Screening system
GB202216515D0 (en) System
GB2602819B (en) Screen System
PL4179320T3 (pl) Układ
GB202108528D0 (en) Screening system
GB202207417D0 (en) Screening system
GB2585055B (en) Separating system
GB2582837B (en) Stand-off screening system
AU2021901970A0 (en) Screening system
GB2611336B (en) Net-launching system
GB202102186D0 (en) Screen system
ZA202109464B (en) Employment-managing system
GB202113813D0 (en) ADDOR system
GB202102363D0 (en) System
GB202101568D0 (en) System
GB202020321D0 (en) X-smart system
GB202018336D0 (en) VxRy system
GB202404685D0 (en) Livewell system
GB202318654D0 (en) System
GB202317255D0 (en) System

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)